ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.

If breast cancer cells have estrogen receptors, they are ER-positive. If they have progesterone receptors, they are PR-positive. One or both of these receptors means the breast cancer is hormone ...

VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Bad news for Spanish MMA. Abdellah Er-Ramy (7-2), a Spanish-Moroccan fighter based in Malaga, tested positive for drostanolone as confirmed by the Nevada Athletic Commission after the Dana White's ...